Combination of human Fas (CD95/Apo-1) ligand with adriamycin significantly enhances the efficacy of antitumor response (Q37729382)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2009
edit
Language Label Description Also known as
English
Combination of human Fas (CD95/Apo-1) ligand with adriamycin significantly enhances the efficacy of antitumor response
scientific article published on June 2009

    Statements

    Combination of human Fas (CD95/Apo-1) ligand with adriamycin significantly enhances the efficacy of antitumor response (English)
    Zhongchen Liu
    Ruizhen Liu
    Jinhua Qiu
    Ping Yin
    Fanghong Luo
    Jinhua Su
    Wenzhu Li
    Caixia Chen
    Xin Fan
    Jiakai Zhang
    Guohong Zhuang
    1 June 2009
    167-174

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit